ABBOTT LABORATORIES — Director's Dealing 2017

Nov 16, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-11-14

Reporting Person: Salvadori Daniel Gesua Sive (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-14	Common shares without par value	M	71157	$38.40	Acquired	144955	Direct
2017-11-14	Common shares without par value	S	71157	$55.00	Disposed	73798	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-14	Option (right to buy)	$38.40	M	71157	Disposed	2026-02-18	Common shares (71157)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.